Endoscopic surveillance intervals in Barrett's oesophagus

Barrett's oesophagus is a premalignant condition where the squamous lining of the distal oesophagus is replaced by specialised columnar epithelium containing goblet cells, usually in response to chronic gastro-oesophageal reflux. Patients face a real lifetime risk of progression to oesophageal adenocarcinoma, a cancer whose prognosis remains poor when detected late. Endoscopic surveillance is central to modern management, aiming to catch dysplasia before invasion occurs.

International gastroenterological societies broadly agree on the principle of regular endoscopic monitoring, yet differ on precise intervals, biopsy strategies, and thresholds for intervention. For clinicians in Australia, where practice is shaped by international evidence alongside local realities such as the Medicare Benefits Schedule and the GP-as-gatekeeper model, interpreting these recommendations is a daily exercise.

What Barrett's oesophagus actually is

The defining feature is the endoscopic appearance of salmon-coloured mucosa extending upward from the gastro-oesophageal junction, confirmed histologically by intestinal metaplasia with goblet cells. Most cases arise with long-standing reflux symptoms, though a notable minority of patients are asymptomatic. Established risk factors include older age, male sex, central obesity, chronic smoking, and a family history of oesophageal adenocarcinoma.

Diagnosis should follow the Prague C&M criteria, documenting both the circumferential and maximal extent of the segment. Standardised description supports clear communication between endoscopists, histopathologists, and the patient's GP, which matters when arranging the next scope or a referral to a tertiary centre such as the Royal Melbourne Hospital or Princess Alexandra in Brisbane. It also supports audit and quality assurance, a focus of GESA credentialing.

Why surveillance matters

The rationale rests on the steep gradient of cancer risk across dysplasia grades. Non-dysplastic Barrett's carries an annual cancer risk of roughly 0.1 to 0.5 percent, while low-grade dysplasia increases this to about 1 percent per year, and high-grade dysplasia to 6 percent or higher. These figures, drawn from large cohort studies, underpin the principle that earlier detection translates into better outcomes.

Over the past two decades, management of dysplastic Barrett's has shifted away from oesophagectomy towards endoscopic therapy, including endoscopic mucosal resection and radiofrequency ablation. Current guidelines focus less on detecting established cancer and more on identifying dysplasia amenable to outpatient endoscopic treatment, reshaping how intervals are calculated.

Guideline intervals compared

Different societies have produced slightly different recommendations, reflecting the strength of available evidence and regional practice patterns. The most commonly referenced intervals for surveillance endoscopy in adults with confirmed Barrett's oesophagus appear below.

These intervals are not rigid rules. Patient factors such as age, comorbidity, family history, and segment length commonly prompt clinicians to adjust timing. Where doubt exists, multidisciplinary discussion at a high-volume centre is the safest course, particularly before ablation therapy.

Endoscopic technique and the Seattle protocol

Modern surveillance relies on high-definition white light endoscopy, often supplemented by virtual or dye-spray chromoendoscopy to highlight subtle mucosal change. The Seattle protocol remains the recommended biopsy strategy: targeted biopsies of any visible lesion plus four-quadrant random biopsies every one to two centimetres along the entire Barrett's segment. Adherence improves dysplasia detection and reduces miss rates.

In Australia, most upper gastrointestinal endoscopy is performed under sedation by gastroenterologists, with a smaller but growing share delivered by nurse endoscopists in selected public hospitals. Reports should always include the Prague classification, biopsy sites, and any suspicious areas photographed or marked, so the next endoscopist can plan the subsequent scope with confidence.

Applying guidelines in Australian healthcare

Australia's two-tiered health system shapes how surveillance is delivered. Public patients typically access endoscopy through outpatient hospital waiting lists, while privately insured patients can often be scoped within weeks at accredited day procedure centres. Either pathway is acceptable, provided quality standards are met, biopsies follow protocol, and results are communicated back to the GP in plain language.

For patients in the bush, distance is a real barrier. Telehealth follow-up is increasingly common, and services such as the Royal Flying Doctor Service help rural and remote patients reach tertiary centres in the capitals. Aboriginal and Torres Strait Islander Australians, who carry a disproportionate burden of oesophageal cancer in some regions, benefit from culturally safe care through Aboriginal Community Controlled Health Organisations.

Practical recommendations for clinicians

Embedding the guidelines into routine practice means standardising the small things that often get missed. The habits below help most teams stay aligned with GESA-endorsed intervals without lengthening the consultation.

• Document the Barrett's segment using the Prague C&M criteria at every endoscopy.
• Apply the Seattle protocol for biopsies unless advanced imaging reliably excludes dysplasia.
• Discuss indeterminate or low-grade dysplasia cases in a multidisciplinary meeting before committing to ablation.
• Use high-definition endoscopes with virtual chromoendoscopy where available, particularly in long-segment disease.
• Communicate the next surveillance date clearly to the patient and the GP, aligned with GESA-endorsed intervals.

These steps align with the push towards structured reporting and quality assurance in Australian endoscopy, where audit against guideline adherence is becoming routine.

The right surveillance interval catches dysplasia early enough to treat endoscopically without unnecessary procedures. Calibrate it to the histology, the segment length, and the person in front of you.